Amira Khater/LinkedIn
Feb 23, 2026, 15:16
Amira Khater: Key Updates on Pulmonary Embolism Management from AHA and ACC Guidelines
Amira Khater, Clinical Pharmacy Specialist at Sentara Healthcare, shared on LinkedIn:
“The AHA and ACC just released their first-ever joint guideline on acute pulmonary embolism, bringing clearer structure to how we diagnose and manage PE.
A few key updates that stood out to me:
- A new A–E classification system to better define PE severity and guide treatment
- DOACs remain first-line for most patients needing anticoagulation
- Advanced therapies like thrombolysis are reserved for higher-risk patients with clinical deterioration
- Greater emphasis on risk stratification and follow-up care
This is an important step toward more consistent, risk-based care—and highlights the ongoing role of the multidisciplinary team in improving outcomes for patients with PE.”
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 18, 2026, 00:33Elad Asher: Does Opening the Clot Change How a Patient Feels Three Months Later?
-
Oct 18, 2026, 00:22Richa Sharma: Evaluating Heterogeneity in Anticoagulation Treatment Effects in Cryptogenic Stroke
-
Oct 18, 2026, 00:07Irem Karaman Sebin: The Evidence Favoring Warfarin in High-Risk Antiphospholipid Syndrome
-
Oct 18, 2026, 00:07Emma Stevens: Lighting Up Buildings in Red and Blue for World Thrombosis Day
-
Oct 17, 2026, 23:18Maha Othman: Establishing ISTH-BAT Reference Ranges for Children and Adolescents
-
Oct 17, 2026, 17:27John Strouse: Building Standards for Whole-Person Sickle Cell Care Through Collaboration
-
Oct 17, 2026, 17:20Jean-Jacques Kiladjian: Exploring the Future of Polycythemia Vera Treatment at MPN Horizons 2026
-
Oct 17, 2026, 17:10Habib Bennaceur: Strengthening Collaboration in Haemophilia, Sickle Cell Disease and Thalassaemia in India
-
Oct 17, 2026, 16:58Danny Hsu: Building Connections at the AUSNBled Collaborative Dinner in Auckland